Thomas J Layden Selected Research

Thomas J Layden Research Topics

7	Infections 03/2013 - 01/2003
6	Fibrosis (Cirrhosis) 07/2012 - 05/2006
4	Hepatitis C 07/2011 - 04/2003
3	Chronic Hepatitis C 08/2007 - 09/2002
2	Viremia 01/2008 - 04/2003
1	Liver Cirrhosis (Hepatic Cirrhosis) 07/2012
1	Disease Progression 01/2010
1	Hepatitis B 07/2009
1	Autoimmune Hepatitis 01/2009
1	Insulin Resistance 01/2008
1	HIV Infections (HIV Infection) 01/2008
1	Diabetes Mellitus 09/2007
1	Hepatocellular Carcinoma (Hepatoma) 11/2005
1	Neoplasms (Cancer) 11/2005
1	Morbid Obesity 10/2004
1	Acute Liver Failure (Fulminant Hepatic Failure) 03/2004
1	Massive Hepatic Necrosis 03/2004
1	Hypertension (High Blood Pressure) 04/2003
1	Obesity 01/2003
1	Coinfection 01/2003
1	Hemolytic Anemia 10/2002
1	Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis) 10/2002
1	Anemia 10/2002
1	Thrombosis (Thrombus) 09/2002

6	InterferonsIBA 01/2008 - 09/2002
3	Ribavirin (Virazole)FDA LinkGeneric 01/2008 - 01/2003
2	Pharmaceutical PreparationsIBA 03/2013 - 04/2009
2	Antiviral Agents (Antivirals)IBA 07/2011 - 01/2008
1	daclatasvirIBA 03/2013
1	Indicators and Reagents (Reagents)IBA 01/2010
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 07/2009
1	RNA (Ribonucleic Acid)IBA 04/2009
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2009
1	Biomarkers (Surrogate Marker)IBA 01/2009
1	A 7 (A-7)IBA 08/2007
1	Carnitine O-Palmitoyltransferase (Carnitine Palmitoyltransferase II)IBA 05/2006
1	Peptides (Polypeptides)IBA 05/2006
1	Proteins (Proteins, Gene)FDA Link 11/2005
1	Disulfiram (Antabuse)FDA Link 03/2004
1	A-factor (Streptomyces)IBA 07/2003
1	interferon alfacon-1 FDA Link 04/2003
1	Immunosuppressive Agents (Immunosuppressants)IBA 04/2003
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 04/2003
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 09/2002

6	Liver Transplantation 07/2012 - 10/2002
5	Therapeutics 01/2008 - 09/2002
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 10/2004
1	Catheters 09/2002